Your browser doesn't support javascript.
loading
The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.
Yamana, Teresa K; Galanti, Marta; Pei, Sen; Di Fusco, Manuela; Angulo, Frederick J; Moran, Mary M; Khan, Farid; Swerdlow, David L; Shaman, Jeffrey.
Afiliación
  • Yamana TK; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
  • Galanti M; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
  • Pei S; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
  • Di Fusco M; Health Economics and Outcomes Research, New York, NY, United States of America.
  • Angulo FJ; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States of America.
  • Moran MM; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States of America.
  • Khan F; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States of America.
  • Swerdlow DL; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Collegeville, PA, United States of America.
  • Shaman J; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, United States of America.
PLoS One ; 18(4): e0275699, 2023.
Article en En | MEDLINE | ID: mdl-37098043
By August 1, 2022, the SARS-CoV-2 virus had caused over 90 million cases of COVID-19 and one million deaths in the United States. Since December 2020, SARS-CoV-2 vaccines have been a key component of US pandemic response; however, the impacts of vaccination are not easily quantified. Here, we use a dynamic county-scale metapopulation model to estimate the number of cases, hospitalizations, and deaths averted due to vaccination during the first six months of vaccine availability. We estimate that COVID-19 vaccination was associated with over 8 million fewer confirmed cases, over 120 thousand fewer deaths, and 700 thousand fewer hospitalizations during the first six months of the campaign.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos